Exhibit 10.1 COR THERAPEUTICS, INC. 5.00% CONVERTIBLE SUBORDINATED NOTES DUE MARCH 1, 2007 PURCHASE AGREEMENTPurchase Agreement • May 10th, 2000 • Cor Therapeutics Inc / De • Pharmaceutical preparations • New York
EXHIBIT 10.1 COR Therapeutics, Inc. 4.50% Convertible Senior Notes due June 15, 2006 Purchase Agreement ------------------Purchase Agreement • August 3rd, 2001 • Cor Therapeutics Inc / De • Pharmaceutical preparations • New York
EXHIBIT 10.2 COR Therapeutics, Inc. 4.50% Convertible Senior Notes due June 15, 2006 Registration Rights Agreement -----------------------------Registration Rights Agreement • August 3rd, 2001 • Cor Therapeutics Inc / De • Pharmaceutical preparations • New York
EXHIBIT 10.2 COR THERAPEUTICS, INC. 5.00% CONVERTIBLE SUBORDINATED NOTES DUE MARCH 1, 2007 REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • May 10th, 2000 • Cor Therapeutics Inc / De • Pharmaceutical preparations • New York
LEASE -----Lease • October 31st, 2001 • Cor Therapeutics Inc / De • Pharmaceutical preparations
EXHIBIT 99.2 AMENDMENT TO RIGHTS AGREEMENT BETWEEN COR THERAPEUTICS, INC. AND MELLON INVESTOR SERVICES LLC THIS AMENDMENT TO RIGHTS AGREEMENT (the "Amendment") is made this 5th day of December, 2001, by and between COR THERAPEUTICS, INC., a Delaware...Rights Agreement • December 7th, 2001 • Cor Therapeutics Inc / De • Pharmaceutical preparations • Delaware
July 27, 2000 Mr. Vaughn M. Kailian, CEO COR Therapeutics, Inc. 256 East Grand Avenue South San Francisco, California 94080 Dear Vaughn: This is with regard to the Collaboration Agreement, dated April 10, 1995, by and among COR Therapeutics, Inc....Collaboration Agreement • November 8th, 2000 • Cor Therapeutics Inc / De • Pharmaceutical preparations
ISSUER TOIndenture • August 3rd, 2001 • Cor Therapeutics Inc / De • Pharmaceutical preparations • New York
1 EXHIBIT 10.26 SECOND AMENDMENT TO THE LICENSE AND SUPPLY AGREEMENT BETWEEN COR THERAPEUTICS AND SOLVAY This Amendment is entered into effective as of the 1st day of June, 1995 between COR THERAPEUTICS, INC. ("COR"), a Delaware corporation, with its...License and Supply Agreement • November 13th, 1998 • Cor Therapeutics Inc / De • Pharmaceutical preparations
ANDCo-Promotion Agreement • May 9th, 2001 • Cor Therapeutics Inc / De • Pharmaceutical preparations • California
COR COR Therapeutics, Inc. ---------------------------------------------------- ----------------------------Stock Option Agreement • October 31st, 2001 • Cor Therapeutics Inc / De • Pharmaceutical preparations
CONFIDENTIAL TREATMENT REQUESTED = [*] CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY BRACKETS, IS FILED WITH THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO RULE 24b-2 OF THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED....Long Term Supply Agreement • November 13th, 1998 • Cor Therapeutics Inc / De • Pharmaceutical preparations • England
AMENDMENT NO. 5 TO COLLABORATION AGREEMENTCollaboration Agreement • March 31st, 1997 • Cor Therapeutics Inc / De • Pharmaceutical preparations
SECOND AMENDMENT TO COLLABORATION AGREEMENT AMONG COR THERAPEUTICS, INC., SCHERING CORPORATION AND SCHERING-PLOUGH, LTD. DATED APRIL 10, 1995Collaboration Agreement • March 30th, 2000 • Cor Therapeutics Inc / De • Pharmaceutical preparations
AMENDMENT NO.1Amendment to the Agreement • March 31st, 1997 • Cor Therapeutics Inc / De • Pharmaceutical preparations
EXHIBIT 99.1 AGREEMENT AND PLAN OF MERGERMerger Agreement • December 7th, 2001 • Cor Therapeutics Inc / De • Pharmaceutical preparations • Delaware
COR COR THERAPEUTICS, INC ----------------------------------------------------- ---------------------------Non-Qualified Stock Option Agreement • October 31st, 2001 • Cor Therapeutics Inc / De • Pharmaceutical preparations
